Gilmore O'Neill, incoming Editas Medicine CEO
With Editas' third CEO in as many years, expect a new CMO and new development partners
Sarepta Therapeutics CMO Gilmore O’Neill will take over as CEO and president of CRISPR biotech Editas Medicine on June 1.
But already in the hours …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
